An Integrated mHealth App for Smoking Cessation in Black Smokers With Anxiety: Protocol for a Randomized Controlled Trial
BackgroundBlack smokers have greater difficulty in quitting and higher rates of smoking-related diseases and disabilities than the general population. The smoking disparities experienced by this group are, in part, a consequence of multiple chronic life stressors (eg, racial...
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
JMIR Publications
2022-05-01
|
| Series: | JMIR Research Protocols |
| Online Access: | https://www.researchprotocols.org/2022/5/e38905 |
| _version_ | 1797735085002194944 |
|---|---|
| author | Michael S Businelle Lorra Garey Matthew W Gallagher Emily T Hébert Anka Vujanovic Adam Alexander Krista Kezbers Cameron Matoska Jillian Robison Audrey Montgomery Michael J Zvolensky |
| author_facet | Michael S Businelle Lorra Garey Matthew W Gallagher Emily T Hébert Anka Vujanovic Adam Alexander Krista Kezbers Cameron Matoska Jillian Robison Audrey Montgomery Michael J Zvolensky |
| author_sort | Michael S Businelle |
| collection | DOAJ |
| description |
BackgroundBlack smokers have greater difficulty in quitting and higher rates of smoking-related diseases and disabilities than the general population. The smoking disparities experienced by this group are, in part, a consequence of multiple chronic life stressors (eg, racial discrimination) that engender increased exposure to interoceptive stress symptoms (eg, anxiety), which can ultimately lead to smoking as a means of immediate emotion regulation.
ObjectiveThis study aimed to culturally adapt and initially test a novel mobile intervention (ie, Mobile Anxiety Sensitivity Program for Smoking [MASP]) that targets anxiety sensitivity (AS; a proxy for difficulty and responsivity to interoceptive stress) among Black smokers. The MASP intervention is culturally informed to address interoceptive stress management difficulties among Black smokers and is thus hypothesized to facilitate smoking cessation.
MethodsIn phase 1, a total of 25 Black smokers with elevated AS will be administered MASP for 6 weeks. Following the completion of phase 1, we will further refine the MASP based on qualitative and quantitative data from participants to produce the final MASP iteration. In phase 2, a total of 200 Black smokers with elevated AS will be enrolled and randomly assigned to receive nicotine replacement therapy and either the smartphone-based National Cancer Institute QuitGuide app for standard mobile smoking cessation treatment or the MASP intervention. All participants in phases 1 and 2 will be enrolled remotely and will complete a web-based study screener; smartphone-based baseline assessment; daily smartphone-based ecological momentary assessments for 6 weeks; phone-based end-of-treatment qualitative interviews; and smartphone-based follow-up assessments at postbaseline weeks 1, 2 (quit date), 3, 4, 5, 6, 28, and 54 (weeks 28 and 54 follow-ups will be completed by phase 2 participants only). The MASP intervention is intended to offset barriers to treatment and encourage treatment engagement via smartphones.
ResultsThis project was funded in September 2020. Phase 1 data collection began in January 2022. Phase 2 data collection is scheduled to begin in July 2022.
ConclusionsIf successful, data from this study will support culturally informed treatment approaches for Black smokers and, pending findings of efficacy, provide an evidence-based mobile intervention for smoking cessation that is ready for dissemination and implementation.
Trial RegistrationClinicalTrials.gov NCT04838236; https://clinicaltrials.gov/ct2/show/NCT04838236
International Registered Report Identifier (IRRID)DERR1-10.2196/38905 |
| first_indexed | 2024-03-12T12:52:56Z |
| format | Article |
| id | doaj.art-d4a7ac860bbe4a008561706a5acafe23 |
| institution | Directory Open Access Journal |
| issn | 1929-0748 |
| language | English |
| last_indexed | 2024-03-12T12:52:56Z |
| publishDate | 2022-05-01 |
| publisher | JMIR Publications |
| record_format | Article |
| series | JMIR Research Protocols |
| spelling | doaj.art-d4a7ac860bbe4a008561706a5acafe232023-08-28T21:52:03ZengJMIR PublicationsJMIR Research Protocols1929-07482022-05-01115e3890510.2196/38905An Integrated mHealth App for Smoking Cessation in Black Smokers With Anxiety: Protocol for a Randomized Controlled TrialMichael S Businellehttps://orcid.org/0000-0002-9038-2238Lorra Gareyhttps://orcid.org/0000-0002-4167-7232Matthew W Gallagherhttps://orcid.org/0000-0001-9734-9329Emily T Héberthttps://orcid.org/0000-0001-5922-164XAnka Vujanovichttps://orcid.org/0000-0002-6099-3046Adam Alexanderhttps://orcid.org/0000-0003-1448-4205Krista Kezbershttps://orcid.org/0000-0002-8387-2781Cameron Matoskahttps://orcid.org/0000-0002-5476-7413Jillian Robisonhttps://orcid.org/0000-0002-5515-2111Audrey Montgomeryhttps://orcid.org/0000-0002-3468-6800Michael J Zvolenskyhttps://orcid.org/0000-0002-1869-0906 BackgroundBlack smokers have greater difficulty in quitting and higher rates of smoking-related diseases and disabilities than the general population. The smoking disparities experienced by this group are, in part, a consequence of multiple chronic life stressors (eg, racial discrimination) that engender increased exposure to interoceptive stress symptoms (eg, anxiety), which can ultimately lead to smoking as a means of immediate emotion regulation. ObjectiveThis study aimed to culturally adapt and initially test a novel mobile intervention (ie, Mobile Anxiety Sensitivity Program for Smoking [MASP]) that targets anxiety sensitivity (AS; a proxy for difficulty and responsivity to interoceptive stress) among Black smokers. The MASP intervention is culturally informed to address interoceptive stress management difficulties among Black smokers and is thus hypothesized to facilitate smoking cessation. MethodsIn phase 1, a total of 25 Black smokers with elevated AS will be administered MASP for 6 weeks. Following the completion of phase 1, we will further refine the MASP based on qualitative and quantitative data from participants to produce the final MASP iteration. In phase 2, a total of 200 Black smokers with elevated AS will be enrolled and randomly assigned to receive nicotine replacement therapy and either the smartphone-based National Cancer Institute QuitGuide app for standard mobile smoking cessation treatment or the MASP intervention. All participants in phases 1 and 2 will be enrolled remotely and will complete a web-based study screener; smartphone-based baseline assessment; daily smartphone-based ecological momentary assessments for 6 weeks; phone-based end-of-treatment qualitative interviews; and smartphone-based follow-up assessments at postbaseline weeks 1, 2 (quit date), 3, 4, 5, 6, 28, and 54 (weeks 28 and 54 follow-ups will be completed by phase 2 participants only). The MASP intervention is intended to offset barriers to treatment and encourage treatment engagement via smartphones. ResultsThis project was funded in September 2020. Phase 1 data collection began in January 2022. Phase 2 data collection is scheduled to begin in July 2022. ConclusionsIf successful, data from this study will support culturally informed treatment approaches for Black smokers and, pending findings of efficacy, provide an evidence-based mobile intervention for smoking cessation that is ready for dissemination and implementation. Trial RegistrationClinicalTrials.gov NCT04838236; https://clinicaltrials.gov/ct2/show/NCT04838236 International Registered Report Identifier (IRRID)DERR1-10.2196/38905https://www.researchprotocols.org/2022/5/e38905 |
| spellingShingle | Michael S Businelle Lorra Garey Matthew W Gallagher Emily T Hébert Anka Vujanovic Adam Alexander Krista Kezbers Cameron Matoska Jillian Robison Audrey Montgomery Michael J Zvolensky An Integrated mHealth App for Smoking Cessation in Black Smokers With Anxiety: Protocol for a Randomized Controlled Trial JMIR Research Protocols |
| title | An Integrated mHealth App for Smoking Cessation in Black Smokers With Anxiety: Protocol for a Randomized Controlled Trial |
| title_full | An Integrated mHealth App for Smoking Cessation in Black Smokers With Anxiety: Protocol for a Randomized Controlled Trial |
| title_fullStr | An Integrated mHealth App for Smoking Cessation in Black Smokers With Anxiety: Protocol for a Randomized Controlled Trial |
| title_full_unstemmed | An Integrated mHealth App for Smoking Cessation in Black Smokers With Anxiety: Protocol for a Randomized Controlled Trial |
| title_short | An Integrated mHealth App for Smoking Cessation in Black Smokers With Anxiety: Protocol for a Randomized Controlled Trial |
| title_sort | integrated mhealth app for smoking cessation in black smokers with anxiety protocol for a randomized controlled trial |
| url | https://www.researchprotocols.org/2022/5/e38905 |
| work_keys_str_mv | AT michaelsbusinelle anintegratedmhealthappforsmokingcessationinblacksmokerswithanxietyprotocolforarandomizedcontrolledtrial AT lorragarey anintegratedmhealthappforsmokingcessationinblacksmokerswithanxietyprotocolforarandomizedcontrolledtrial AT matthewwgallagher anintegratedmhealthappforsmokingcessationinblacksmokerswithanxietyprotocolforarandomizedcontrolledtrial AT emilythebert anintegratedmhealthappforsmokingcessationinblacksmokerswithanxietyprotocolforarandomizedcontrolledtrial AT ankavujanovic anintegratedmhealthappforsmokingcessationinblacksmokerswithanxietyprotocolforarandomizedcontrolledtrial AT adamalexander anintegratedmhealthappforsmokingcessationinblacksmokerswithanxietyprotocolforarandomizedcontrolledtrial AT kristakezbers anintegratedmhealthappforsmokingcessationinblacksmokerswithanxietyprotocolforarandomizedcontrolledtrial AT cameronmatoska anintegratedmhealthappforsmokingcessationinblacksmokerswithanxietyprotocolforarandomizedcontrolledtrial AT jillianrobison anintegratedmhealthappforsmokingcessationinblacksmokerswithanxietyprotocolforarandomizedcontrolledtrial AT audreymontgomery anintegratedmhealthappforsmokingcessationinblacksmokerswithanxietyprotocolforarandomizedcontrolledtrial AT michaeljzvolensky anintegratedmhealthappforsmokingcessationinblacksmokerswithanxietyprotocolforarandomizedcontrolledtrial AT michaelsbusinelle integratedmhealthappforsmokingcessationinblacksmokerswithanxietyprotocolforarandomizedcontrolledtrial AT lorragarey integratedmhealthappforsmokingcessationinblacksmokerswithanxietyprotocolforarandomizedcontrolledtrial AT matthewwgallagher integratedmhealthappforsmokingcessationinblacksmokerswithanxietyprotocolforarandomizedcontrolledtrial AT emilythebert integratedmhealthappforsmokingcessationinblacksmokerswithanxietyprotocolforarandomizedcontrolledtrial AT ankavujanovic integratedmhealthappforsmokingcessationinblacksmokerswithanxietyprotocolforarandomizedcontrolledtrial AT adamalexander integratedmhealthappforsmokingcessationinblacksmokerswithanxietyprotocolforarandomizedcontrolledtrial AT kristakezbers integratedmhealthappforsmokingcessationinblacksmokerswithanxietyprotocolforarandomizedcontrolledtrial AT cameronmatoska integratedmhealthappforsmokingcessationinblacksmokerswithanxietyprotocolforarandomizedcontrolledtrial AT jillianrobison integratedmhealthappforsmokingcessationinblacksmokerswithanxietyprotocolforarandomizedcontrolledtrial AT audreymontgomery integratedmhealthappforsmokingcessationinblacksmokerswithanxietyprotocolforarandomizedcontrolledtrial AT michaeljzvolensky integratedmhealthappforsmokingcessationinblacksmokerswithanxietyprotocolforarandomizedcontrolledtrial |